Yuan Ren

发表

Roles of Gab1 and SHP2 in Paxillin Tyrosine Dephosphorylation and Src Activation in Response to Epidermal Growth Factor*

R. Jove, Yuan Ren, Songshu Meng, 2004, Journal of Biological Chemistry.

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

D. Coppola, Yuan Ren, C. Appleyard, 2011, World journal of gastroenterology.

Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.

D. Coppola, Yuan Ren, C. Appleyard, 2010, Anticancer research.

Venetoclax as a single agent and in combination with PI3K‐MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma

Yuan Ren, L. Moscinski, J. Tao, 2019, British journal of haematology.

Palmadorin chemodiversity from the Antarctic nudibranch Austrodoris kerguelenensis and inhibition of Jak2/STAT5-dependent HEL leukemia cells

Yuan Ren, Jie Wu, C. Amsler, 2012 .

Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo

Yuan Ren, Hua Cheng, Yi Zhang, 2012, Molecular Biology Reports.

The expression of stem cell protein Piwil2 and piR-932 in breast cancer.

H. Zhang, Yuan Ren, Caigang Liu, 2013, Surgical oncology.

Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease

Yuan Ren, Hang Zhu, Wei-ren Wan, 2011, Molecular Biology Reports.

Mechanisms regulating c‐met overexpression in liver‐metastatic B16‐LS9 melanoma cells

Yuan Ren, R. Zarnegar, M. Burger, 2001, Journal of cellular biochemistry.

Shp2E76K Mutant Confers Cytokine-independent Survival of TF-1 Myeloid Cells by Up-regulating Bcl-XL*

J. Cheng, Yuan Ren, Jie Wu, 2007, Journal of Biological Chemistry.

JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations

Richard Z. Liu, Yuan Ren, Jie Wu, 2013, Scientific Reports.

Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

W. Guida, Yuan Ren, Jie Wu, 2010, Biochemical pharmacology.

SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.

Yuan Ren, Eric B Haura, Domenico Coppola, 2014, Carcinogenesis.

Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor

W. Guida, Yuan Ren, Jie Wu, 2006, Molecular Pharmacology.

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

D. Coppola, Yuan Ren, Jie Wu, 2015, Oncotarget.

Regulation of the Mitogen-activated Protein Kinase Signaling Pathway by SHP2*

C. Desponts, Yuan Ren, Songshu Meng, 2002, The Journal of Biological Chemistry.

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.

K. Fu, Mousheng Xu, A. Silva, 2019, Cancer cell.

Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer

H. Zhang, Yuan Ren, Caigang Liu, 2014, World Journal of Surgical Oncology.

Critical role of Shp2 in tumor growth involving regulation of c-Myc.

Yuan Ren, Jie Wu, E. Haura, 2010, Genes & cancer.

ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells

Yuan Ren, Jia Liu, Weifan Cao, 2020, Clinical and translational medicine.

Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma

A. Silva, J. Qi, J. Cleveland, 2021, Cell reports.

Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90

P. Atadja, Yuan Ren, Jie Wu, 2007, Clinical Cancer Research.

PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

K. Fu, J. Vose, A. Silva, 2018, The Journal of clinical investigation.

PLK 1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

K. Fu, J. Vose, A. Silva, 2018 .

Is concomitant splenectomy beneficial for the long-term survival of patients with gastric cancer undergoing curative gastrectomy? A single-institution study

H. Zhang, Yuan Ren, Caigang Liu, 2014, World Journal of Surgical Oncology.

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas

Yuan Ren, J. Tao, Xiaohong Zhao, 2021, Haematologica.

Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo

Yuan Ren, Hua Cheng, Yi Zhang, 2011, Molecular Biology Reports.

PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas

Yuan Ren, Jie Wu, J. Messina, 2018, Molecular Cancer Research.

EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway

Yuan Ren, Lijun Zhang, Hao Zhang, 2016, Tumor Biology.

Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma

Yuan Ren, M. Zheng, Kai Wang, 2019, OncoTargets and therapy.

OTT_A_212200 7269..7279

Yuan Ren, M. Zheng, Kai Wang, 2019 .

Overexpression of TRMT 12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma

Yuan Ren, M. Zheng, Kai Wang, 2019 .

Targeting Kinome Reprogramming for Overcoming Ibrutinib-Resistance (IR) in Mantle Cell Lymphoma (MCL)

Yuan Ren, J. Tao, Huijuan Jiang, 2018, Blood.

SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.

D. Coppola, Yuan Ren, Jie Wu, 2014, Carcinogenesis.